Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia

International Journal of Pharmaceutics

Volumn 304, Issue 1-2, 2005, Pages 51-62

  Deng, Rong ^a   Balthasar, Joseph P ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antibody coated liposome; Immune thrombocytopenia

Indexed keywords

IMMUNOGLOBULIN G1 ANTIBODY; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG COATING; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOCYTOPENIA;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; COMPLEMENT C3; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOGLOBULIN G; LIPOSOMES; MACROPHAGES, ALVEOLAR; PHAGOCYTOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FC;

EID: 26444529477     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.07.019     Document Type: Article

References (51)

1. F. Ahsan, I.P. Rivas, M.A. Khan, and A.I. Torres Suarez Targeting to macrophages: role of physicochemical properties of particulate carriers - liposomes and microspheres - on the phagocytosis by macrophages J. Control. Release 79 2002 29 40
2. T.M. Allen, and D.D. Stuart Liposome pharmacokinetics: classical, sterically stabilized, cationic liposomes and immunoliposomes A.S. Janoff Liposomes: Rational Design 1999 Marcel Dekker New York
3. F. Alves-Rosa, C. Stanganelli, J. Cabrera, N. van Rooijen, M.S. Palermo, and M.A. Isturiz Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model Blood 96 2000 2834 2840
4. J.P. Balthasar, and H.L. Fung Inverse targeting of peritoneal tumors: selective alteration of the disposition of methotrexate through the use of anti-methotrexate antibodies and antibody fragments J. Pharm. Sci. 85 1996 1035 1043
5. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
6. M. Basta Modulation of complement-mediated immune damage by intravenous immune globulin Clin. Exp. Immunol. 104 1996 21 25
7. N. Berger, A. Sachse, J. Bender, R. Schubert, and M. Brandl Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics Int. J. Pharm. 223 2001 55 68
8. G.V. Betageri, C.D. Black, J. Szebeni, L.M. Wahl, and J.N. Weinstein Fc-receptor-mediated targeting of antibody-bearing liposomes containing dideoxycytidine triphosphate to human monocyte/macrophages J. Pharm. Pharmacol. 45 1993 48 53
9. V. Blanchette, J. Freedman, and B. Garvey Management of chronic immune thrombocytopenic purpura in children and adults Semin. Hematol. 35 1998 36 51
10. A.J. Bradley, and D.V. Devine The complement system in liposome clearance: can complement deposition be inhibited? Adv. Drug Deliv. Rev. 32 1998 19 29
11. J.B. Bussel Fc receptor blockade and immune thrombocytopenic purpura Semin. Hematol. 37 2000 261 266
12. J.B. Bussel, J.N. Graziano, R.P. Kimberly, S. Pahwa, and L.M. Aledort Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect Blood 77 1991 1884 1893
13. D.B. Cines, and V.S. Blanchette Immune thrombocytopenic purpura N. Engl. J. Med. 346 2002 995 1008
14. S.B. Clarkson, J.B. Bussel, R.P. Kimberly, J.E. Valinsky, R.L. Nachman, and J.C. Unkeless Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody N. Engl. J. Med. 314 1986 1236 1239
15. R. Clynes, and J.V. Ravetch Cytotoxic antibodies trigger inflammation through Fc receptors Immunity 3 1995 21 26
16. L.M. Coetzee, H. Pieters, V. van Wyk, S. Cooper, J. Roodt, S. De Reys, and P.N. Badenhorst The effect of monoclonal anti-human-platelet antibodies on platelet kinetics in a baboon model: IgG subclass dependency Thromb. Haemost. 83 2000 148 156
17. T.M. Cosgriff, M.L. Black, and W. Stein 3rd Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin Am. J. Hematol. 57 1998 85 86
18. M. Debre, M.C. Bonnet, W.H. Fridman, E. Carosella, N. Philippe, P. Reinert, E. Vilmer, C. Kaplan, J.L. Teillaud, and C. Griscelli Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura Lancet 342 1993 945 949
19. J.T. Derksen, H.W. Morselt, and G.L. Scherphof Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages Biochim. Biophys. Acta 971 1988 127 136
20. S.J. Gebran, E.L. Romano, H.A. Pons, L. Cariani, and A.N. Soyano A modified colorimetric method for the measurement of phagocytosis and antibody-dependent cell cytotoxicity using 2,7-diaminofluorene J. Immunol. Methods 151 1992 255 260
21. J.N. George, S.H. Woolf, G.E. Raskob, J.S. Wasser, L.M. Aledort, P.J. Ballem, V.S. Blanchette, J.B. Bussel, D.B. Cines, J.G. Kelton, A.E. Lichtin, R. McMillan, J.A. Okerbloom, D.H. Regan, and I. Warrier Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology Blood 88 1996 3 40
22. C.B. Hansen, G.Y. Kao, E.H. Moase, S. Zalipsky, and T.M. Allen Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures Biochim. Biophys. Acta 1239 1995 133 144
23. R.J. Hansen, and J.P. Balthasar Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura J. Pharmacol. Exp. Ther. 298 2001 165 171
24. R.J. Hansen, and J.P. Balthasar Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia Blood 100 2002 2087 2093
25. T.D. Heath, B.A. Macher, and D. Papahadjopoulos Covalent attachment of immunoglobulins to liposomes via glycosphingolipids Biochim. Biophys. Acta 640 1981 66 81
26. J. Hed Role of complement in immune or idiopathic thrombocytopenic purpura Acta Paediatr. Suppl. 424 1998 37 40
27. R.J. Helmke, V.F. German, and J.A. Mangos A continuous alveolar macrophage cell line: comparisons with freshly derived alveolar macrophages In vitro Cell. Dev. Biol. 25 1989 44 48
28. M.J. Hsu, and R.L. Juliano Interactions of liposomes with the reticuloendothelial system. II: nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages Biochim. Biophys. Acta 720 1982 411 419
29. P. Imbach, S. Barandun, V. D'Apuzzo, C. Baumgartner, A. Hirt, A. Morell, E. Rossi, M. Schoni, M. Vest, and H.P. Wagner High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood Lancet 1 1981 1228 1231
30. Y. Kurata, J.G. Curd, J.D. Tamerius, and R. McMillan Platelet-associated complement in chronic ITP Br. J. Haematol. 60 1985 723 733
31. C. Larroche, Y. Chanseaud, P. Garcia de la Pena-Lefebvre, and L. Mouthon Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders BioDrugs 16 2002 47 55
32. E.D. Lobo, D.M. Soda, and J.P. Balthasar Application of pharmacokinetic-pharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice J. Pharm. Sci. 92 2003 1665 1676
33. R. McMillan Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura Semin. Hematol. 37 2000 239 248
34. N.L. Meryhew, R.P. Messner, K.R. Wasiluk, and O.A. Runquist Assessment of mononuclear phagocytic system function by clearance of anti-D-sensitized erythrocytes: the role of complement J. Lab. Clin. Med. 105 1985 277 281
35. T.E. Mollnes, I.H. Andreassen, K. Hogasen, C.E. Hack, and M. Harboe Effect of whole and fractionated intravenous immunoglobulin on complement in vitro Mol. Immunol. 34 1997 719 729
36. T.E. Mollnes, K. Hogasen, B.F. Hoaas, T.E. Michaelsen, P. Garred, and M. Harboe Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties Scand. J. Immunol. 41 1995 449 456
37. S. Nomura, Y. Miyazaki, T. Miyake, K. Yamaguchi, H. Kido, T. Kawakatsu, T. Fukuroi, H. Kagawa, M. Suzuki, and M. Yanabu IgG inhibits the increase of platelet-associated C3 stimulated by anti-platelet antibodies Clin. Exp. Immunol. 93 1993 452 455
38. H.R. Petty, D.G. Hafeman, and H.M. Mcconnell Specific antibody-dependent phagocytosis of lipid vesicles by RAW264 macrophages results in the loss of cell surface Fc but not C3b receptor activity J. Immunol. 125 1980 2391 2396
39. W.N. Prodinger, R. Wurzner, A. Erdei, and M.P. Dierich Complement W.E. Paul Fundamental Immunology 1999 Lippincott New York
40. R. Rieben, A. Roos, Y. Muizert, C. Tinguely, A.F. Gerritsen, and M.R. Daha Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation Blood 93 1999 942 951
41. E. Rochna, and N.C. Hughes-Jones The use of purified 125-I-labelled anti-gamma globulin in the determination of the number of D antigen sites on red cells of different phenotypes Vox Sang. 10 1965 675 686
42. F. Rodriguez-Vico, M. Martinez-Cayuela, E. Garcia-Peregrin, and H. Ramirez A procedure for eliminating interferences in the Lowry method of protein determination Anal. Biochem. 183 1989 275 278
43. G. Rouser, S. Fkeischer, and A. Yamamoto Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots Lipids 5 1970 494 496
44. E. Sada, S. Katoh, M. Terashima, H. Kawahara, and M. Katoh Effects of surface charges and cholesterol content on amino acid permeabilities of small unilamellar vesicles J. Pharm. Sci. 79 1990 232 235
45. A. Salama, V. Kiefel, and C. Mueller-Eckhardt Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia Am. J. Hematol. 22 1986 241 250
46. A. Salama, C. Mueller-Eckhardt, and V. Kiefel Effect of intravenous immunoglobulin in immune thrombocytopenia Lancet 2 1983 193 195
47. A. Scaradavou, B. Woo, B.M. Woloski, S. Cunningham-Rundles, L.J. Ettinger, L.M. Aledort, and J.B. Bussel Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients Blood 89 1997 2689 2700
48. V. Siragam, D. Brinc, A.R. Crow, S. Song, J. Freedman, and A.H. Lazarus Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? J. Clin. Invest. 115 2005 155 160
49. S. Song, A.R. Crow, J. Freedman, and A.H. Lazarus Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG Blood 101 2003 3708 3713
50. C.L. Wagner, M.A. Mascelli, D.S. Neblock, H.F. Weisman, B.S. Coller, and R.E. Jordan Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets Blood 88 1996 907 914
51. R.E. Ware, and S.A. Zimmerman Anti-D: mechanisms of action Semin. Hematol. 35 1998 14 22